“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a five year holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Regeneron Pharmaceuticals, Inc. (NASD: REGN)? Today, we examine the outcome of a five year investment into the stock back in 2014.
| Start date: | 09/12/2014 |
|
|||
| End date: | 09/11/2019 | ||||
| Start price/share: | $346.06 | ||||
| End price/share: | $283.33 | ||||
| Starting shares: | 28.90 | ||||
| Ending shares: | 28.90 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | -18.13% | ||||
| Average annual return: | -3.92% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $8,187.76 | ||||
As we can see, the five year investment result worked out poorly, with an annualized rate of return of -3.92%. This would have turned a $10K investment made 5 years ago into $8,187.76 today (as of 09/11/2019). On a total return basis, that’s a result of -18.13% (something to think about: how might REGN shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
More investment wisdom to ponder:
“In the short run, the market is a voting machine but in the long run, it is a weighing machine.” — Benjamin Graham
